EQS-News: Imcyse joins CLAIMS, a European Health Initiative Project to Make Data-Driven Precision Medicine a Reality for Patients with Multiple Sclerosis
Retrieved on:
Thursday, June 22, 2023
The project, launched at the start of June, has total funding of almost 10 million Euros, contributed by industry partners and the European Commission and will run over the next four years.
Key Points:
- The project, launched at the start of June, has total funding of almost 10 million Euros, contributed by industry partners and the European Commission and will run over the next four years.
- The goal is to develop a companion diagnostic platform supporting the assessment of disease worsening in patients with multiple sclerosis (MS), making data-driven precision medicine a reality for this group.
- “MS is a devastating and highly unpredictable disease that affects everyone differently with a continued high need for effective and safe treatments.
- The diversity of the consortium is a true asset, ensuring all necessary expertise is available to achieve its challenging goals.